Gf Fund Management Co. Ltd. Akero Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,787 shares of AKRO stock, worth $76,912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,787
Previous 1,466
21.9%
Holding current value
$76,912
Previous $40.8 Million
77.37%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AKRO
# of Institutions
212Shares Held
67.8MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$295 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$260 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$240 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$225 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$186 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...